Cerevel Therapeutics Hldg Inc (CERE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CERE | MDGL | CNTA | ||
| Company | Cerevel Therapeutics Hldg Inc | Madrigal Pharmaceuticals Inc | Centessa Pharmaceuticals Plc ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 44.99 | 517.00 | 39.45 | ||
| High | 44.99 | 517.00 | 39.45 | ||
| Low | 44.96 | 517.00 | 39.45 | ||
| Latest | 44.96 | 512.73 | 39.64 | ||
| Change | +0.33 | -0.99 | +0.07 | ||
| % Change | +0.74% | -0.19% | +0.18% | ||
| Volume | 15,096,300 | 185 | 1,602 | ||
| 20-Day Average Volume | 2,839,210 | 247,329 | 2,385,320 | ||
| Previous Close | 44.63 | 513.72 | 39.57 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 42.53 | 521.01 | 39.53 | ||
| 20-Day Raw Stochastic | 99.49% | 41.97% | 45.31% | ||
| 20-Day Relative Strength | 68.05 | 54.31 | 71.26 | ||
| Weighted Alpha | +49.03 | +64.38 | +128.37 | ||
| Today's Opinion | 72% Buy | 56% Buy | 88% Buy | ||
| Previous Opinion | 72% Buy | 56% Buy | 100% Buy | ||
| Last Month's Opinion | 8% Buy | 40% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.67% since 07/24/24 | -0.59% since 04/27/26 | -0.15% since 04/27/26 | ||
| Low | 43.75 on 07/25/24 | 501.59 on 04/29/26 | 39.35 on 04/30/26 | ||
| High | 44.99 on 07/31/24 | 528.28 on 04/28/26 | 39.60 on 05/01/26 | ||
| 1-Month | |||||
| %Chg | +9.95% since 06/28/24 | -5.47% since 04/02/26 | -0.60% since 04/02/26 | ||
| Low | 39.16 on 07/03/24 | 500.97 on 04/24/26 | 39.16 on 04/13/26 | ||
| High | 44.99 on 07/31/24 | 547.18 on 04/06/26 | 39.80 on 04/09/26 | ||
| 3-Month | |||||
| %Chg | +5.27% since 04/30/24 | +8.02% since 02/04/26 | +57.80% since 02/04/26 | ||
| Low | 38.50 on 06/25/24 | 416.21 on 03/03/26 | 22.50 on 02/11/26 | ||
| High | 44.99 on 07/31/24 | 572.20 on 03/26/26 | 40.26 on 03/31/26 | ||
| 6-Month | |||||
| %Chg | +6.82% since 01/30/24 | +16.27% since 11/04/25 | +66.18% since 11/04/25 | ||
| Low | 38.50 on 06/25/24 | 416.21 on 03/03/26 | 17.05 on 11/05/25 | ||
| High | 44.99 on 07/31/24 | 615.00 on 12/24/25 | 40.26 on 03/31/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 8,191,488 | 11,837,130 | 5,904,952 | ||
| Shares Outstanding, K | 182,195 | 23,042 | 149,228 | ||
| Annual Sales | 0 | 958,400,000 | 15,000,000 | ||
| Annual Net Income | -432,840,000 | -288,280,000 | -197,530,000 | ||
| Last Quarter Sales | 0 | 321,080,000 | 0 | ||
| Last Quarter Net Income | -131,910,000 | -58,570,000 | -66,160,000 | ||
| 60-Month Beta | 1.40 | -1.04 | 1.14 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.73 on 05/08/24 | -2.57 on 02/19/26 | -0.48 on 03/31/26 | ||
| Earnings Date | 08/07/24 | 05/06/26 | 05/13/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||